717
Views
34
CrossRef citations to date
0
Altmetric
Review

Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung diseases (2010 – 2014)

, MD & (Professor)

Bibliography

  • Nauseef WM. How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev 2007;219:88-102
  • Henriksen PA. The potential of neutrophil elastase inhibitors as anti-inflammatory therapies. Cur Opin Hematol 2014;21(1):23-8
  • Hoenderdos K, Condliffe A. The neutrophil in chronic obstructive pulmonary disease. Am J Respir Cell Molecul Biol 2013;48(5):531-9
  • Pipoly DJ, Crouch EC. Degradation of native type IV procollagen by human neutrophil elastase. Implications for leukocyte-mediated degradation of basement membranes. Biochemistry 1987;26(18):5748-54
  • Stein RL, Strimpler AM. Catalysis by human leukocyte elastase. Aminolysis of acyl-enzymes by amino acid amides and peptides. Biochemistry 1987;26(8):2238-42
  • Anderssen T, Halvorsen H, Bajaj SP, Osterud B. Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis. Thromb Haemost 1993;70(3):414-17
  • Turkington PT. Degradation of human factor X by human polymorphonuclear leucocyte cathepsin G and elastase. Haemostasis 1991;21(2):111-16
  • Doring G. The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med 1994;150(6 Pt 2):S114-17
  • Moraes TJ, Chow CW, Downey GP. Proteases and lung injury. Crit Care Med 2003;31(4 Suppl):S189-94
  • Stockley RA. The role of proteinases in the pathogenesis of chronic bronchitis. Am J Respir Crit Care Med 1994;150(6 Pt 2):S109-13
  • Wiener-Kronish JP, Gropper MA, Matthay MA. The adult respiratory distress syndrome: definition and prognosis, pathogenesis and treatment. Br J Anaesth 1990;65(1):107-29
  • Wang Y, Xiao Y, Zhong L, et al. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with beta-cell autoimmunity in patients with type 1 diabetes. Diabetes 2014;63(12):4239-48
  • Schrijver G, Schalkwijk J, Robben JC, et al. Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase. J Experim Med 1989;169(4):1435-48
  • Yokoyama T, Tsushima K, Ushiki A, et al. Acute lung injury with alveolar hemorrhage due to a novel swine-origin influenza A (H1N1) virus. Int Med 2010;49(5):427-30
  • Tagami T, Tosa R, Omura M, et al. Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema Study. J Inten Care 2014;2(1):67
  • Zeiher BG, Artigas A, Vincent JL, et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 2004;32(8):1695-702
  • Kroegel C, Foerster M. Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast. Expert Opin Investig Drugs 2007;16(1):109-24
  • Matera MG, Rogliani P, Calzetta L, Cazzola M. Phosphodiesterase inhibitors for chronic obstructive pulmonary disease: what does the future hold? Drugs 2014;74(17):1983-92
  • Campbell EJ, Silverman EK, Campbell MA. Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J Immunol 1989;143(9):2961-8
  • Lungarella G, Menegazzi R, Gardi C, et al. Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch Biochem Biophys 1992;292(1):128-35
  • Tsuji N, Moriwaki S, Suzuki Y, et al. The role of elastases secreted by fibroblasts in wrinkle formation: implication through selective inhibition of elastase activity. Photochem Photobiol 2001;74(2):283-90
  • Liou TG, Campbell EJ. Nonisotropic enzyme--inhibitor interactions: a novel nonoxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 1995;34(49):16171-7
  • Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003;5(14):1317-27
  • Perera NC, Schilling O, Kittel H, et al. NSP4, an elastase-related protease in human neutrophils with arginine specificity. Proc Nat Acad Sci USA 2012;109(16):6229-34
  • Zimmer M, Medcalf RL, Fink TM, et al. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Nat Acad Sci USA 1992;89(17):8215-19
  • Horwitz MS, Duan Z, Korkmaz B, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 2007;109(5):1817-24
  • Taggart CC, Greene CM, Carroll TP, et al. Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease. Am J Respir Crit Care Med 2005;171(10):1070-6
  • Wiedow O, Meyer-Hoffert U. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Int Med 2005;257(4):319-28
  • Devaney JM, Greene CM, Taggart CC, et al. Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett 2003;544(1-3):129-32
  • Bank U, Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol 2001;69(2):197-206
  • Mihara K, Ramachandran R, Renaux B, et al. Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1). J Biol Chem 2013;288(46):32979-90
  • Suzuki T, Yamashita C, Zemans RL, et al. Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway. Am J Respir Cell Molecul Biol 2009;41(6):742-55
  • Zhou J, Perelman JM, Kolosov VP, Zhou X. Neutrophil elastase induces MUC5AC secretion via protease-activated receptor 2. Mol Cell Biochem 2013;377(1-2):75-85
  • Hirche TO, Crouch EC, Espinola M, et al. Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain. J Biol Chem 2004;279(26):27688-98
  • Beaufort N, Leduc D, Rousselle JC, et al. Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G. J Immunol 2004;172(1):540-9
  • Doring G, Frank F, Boudier C, et al. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J Immunol 1995;154(9):4842-50
  • Nadel JA. Role of mast cell and neutrophil proteases in airway secretion. Am Rev Respir Dis 1991;144(3 Pt 2):S48-51
  • Rogalski C, Meyer-Hoffert U, Proksch E, Wiedow O. Human leukocyte elastase induces keratinocyte proliferation in vitro and in vivo. J Invest Dermatol 2002;118(1):49-54
  • Renesto P, Chignard M. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation. Blood 1993;82(1):139-44
  • Starcher B, O’Neal P, Granstein RD, Beissert S. Inhibition of neutrophil elastase suppresses the development of skin tumors in hairless mice. J Invest Dermatol 1996;107(2):159-63
  • Sun Z, Yang P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol 2004;5(3):182-90
  • Gadek JE, Pacht ER. The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung 1990;168 Suppl:552-64
  • Perlmutter DH. Alpha-1-antitrypsin deficiency: biochemistry and clinical manifestations. Ann Med 1996;28(5):385-94
  • Silverman GA, Bird PI, Carrell RW, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Bio Chem 2001;276(36):33293-6
  • Sottrup-Jensen L. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem 1989;264(20):11539-42
  • Travis J. Structure, function, and control of neutrophil proteinases. Am J Med 1988;84(6A):37-42
  • Owen CA, Campbell EJ. The cell biology of leukocyte-mediated proteolysis. J Leuk Biol 1999;65(2):137-50
  • Sarker RS, John-Schuster G, Bohla A, et al. CARM1 regulates alveolar epithelial senescence and elastase-induced emphysema susceptibility. Am J Respir Cell Molecul Biol 2015. [Epub ahead of print]
  • Li Q, Li N, Liu CY, et al. Ezrin/Exocyst complex regulates mucin 5AC secretion induced by neutrophil elastase in human airway epithelial cells. Cell Physiol Biochem 2015;35(1):326-38
  • Sabater JR, Lee TA, Abraham WM. Comparative effects of salmeterol, albuterol, and ipratropium on normal and impaired mucociliary function in sheep. Chest 2005;128(5):3743-9
  • Juvelekian GS, Stoller JK. Augmentation therapy for alpha(1)-antitrypsin deficiency. Drugs 2004;64(16):1743-56
  • Hwang TL, Wang WH, Wang TY, et al. Synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3. Bioorg Med Chem 2015;23(5):1123-34
  • Tsai YF, Yu HP, Chang WY, et al. Sirtinol inhibits neutrophil elastase activity and attenuates lipopolysaccharide-mediated acute lung injury in mice. Scientific Reports 2015;5:8347
  • Wright JL, Farmer SG, Churg A. Synthetic serine elastase inhibitor reduces cigarette smoke-induced emphysema in guinea pigs. Am J Respir Crit Care Med 2002;166(7):954-60
  • Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010;62(4):726-59
  • Garcia SN, Van DNW, Carreno SC, et al. Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions. CA2751436A1; 2010
  • DeMarco SJ, Moehle K, Henze H, et al. Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity. US8658604B2; 2014
  • Thongyoo P, Bonomelli C, Leatherbarrow RJ, Tate EW. Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold. J Med Chem 2009;52(20):6197-200
  • Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochimica et Biophysica Acta 1985;823(1):35-65
  • Lawrence DA, Stefansson SP. Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof. CA2233670C; 2012
  • Shinguh Y, Imai K, Yamazaki A, et al. Biochemical and pharmacological characterization of FK706, a novel elastase inhibitor. Eur J Pharmacol 1997;337(1):63-71
  • Kawabata K, Suzuki M, Sugitani M, et al. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 1991;177(2):814-20
  • Kawabata K, Moore AR, Willoughby DA. Impaired activity of protease inhibitors towards neutrophil elastase bound to human articular cartilage. Ann Rheum Dis 1996;55(4):248-52
  • Iba T, Kidokoro A, Fukunaga M, et al. Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters. Shock 2006;26(1):95-8
  • Jagwani D, Joshi P. A greener chemistry approach for synthesis of 4-(4-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4 tetrahydropyrimidine-5-carboxylic acid ethyl ester. Int J Pharmaceut Sci Res 2015;6(2):783-90
  • Hansen G, Gielen-Haertwig H, Reinemer P, et al. Unexpected active-site flexibility in the structure of human neutrophil elastase in complex with a new dihydropyrimidone inhibitor. J Mol Biol 2011;409(5):681-91
  • Von Nussbaum F, Karthaus D, Anlauf S, et al. 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use. US8288402B2; 2012
  • GNAMM C, Oost T, Peters S, Rudolf K. Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity. US0249129A1; 2014
  • FINCH HADLTD. Edwards C, Fitzgerald MF, et al. Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors. EP1856059B1; 2010
  • Bergström L, Lönn H, Lundkvist M, Sjö P. Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors. US0003858A1; 2011
  • Ray NC, Finch H, Edwards C, O’connor E. Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors. EP2024367B1; 2010
  • Blench TJ, Edwards C, Heald RA, et al. Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors. WO037809A1; 2013
  • Gielen-Haertwig H, Albrecht B, Keldenich J, et al. 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors. EP1723121B1; 2012
  • Edwards C, Kulagowski J, Finch H. Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd. WO110858A1; 2011
  • Hansen P, Ivarsson M, Lawitz K, et al. 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. CA2650553C; 2014
  • Ainge D, Chapman D, Lindsjo M, et al. Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase. US0280048A1; 2010
  • Murugan A, Ashton M, Bergstrom LK, et al. 2-pyridone compounds used as inhibitors of neutrophil elastase. EP2483244A1; 2012
  • Andersson M, Hansen P, LÖNN H, et al. 2-pyridone derivatives as neutrophil elastase inhibitors and their use. EP1663973B1; 2013
  • Oost T, FIEGEN D, GNAMM C, et al. Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity. US0057916A1; 2014
  • Shreder K, Hu Y, Fraser A, et al. Serine hydrolase inhibitors. EP2066662B1; 2012
  • Hsieh PW, Yu HP, Chang YJ, Hwang TL. Synthesis and evaluation of benzoxazinone derivatives on activity of human neutrophil elastase and on hemorrhagic shock-induced lung injury in rats. Eur J Med Chem 2010;45(7):3111-15
  • Shreder KR, Cajica J, Du L, et al. Synthesis and optimization of 2-pyridin-3-yl-benzo[d][1,3]oxazin-4-one based inhibitors of human neutrophil elastase. Bioor Med Chem Let 2009;19(16):4743-6
  • Hsieh PW, Hwang TL, Wu CC, et al. The evaluation of 2,8-disubstituted benzoxazinone derivatives as anti-inflammatory and anti-platelet aggregation agents. Bioor Med Chem Let 2005;15(11):2786-9
  • Wong T, Groutas CS, Mohan S, et al. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase. Arch Biochem Biophys 2005;436(1):1-7
  • Ahmed T, Abraham W. Hypersulfated disaccharides to treat elastase related disorders. CN103269585A; 2013
  • Groutas WC, Huang H, Epp JB, et al. Mechanism-based inhibition of human leukocyte elastase and cathepsin G by substituted dihydrouracils. Biochim Biophys Acta 1994;1227(3):130-6
  • Shiro T, Tobe M, Kubota K, et al. Uracil derivative and use thereof for medical purposes. US0179670A1; 2014
  • Isobe Y, Tobe M, Inoue Y, et al. Structure and activity relationships of novel uracil derivatives as topical anti-inflammatory agents. Bioor Med Chem 2003;11(23):4933-40
  • Walker RT, Jones AS, De Clercq E, et al. The synthesis and properties of some 5-substituted uracil derivatives. Nucleic Acids Symp Ser 1980(8):s95-102
  • Bayerl T. Use of deuterium oxide as an elastase inhibitor. WO2009130615A3; 2010
  • Perona JJ, Craik CS. Structural basis of substrate specificity in the serine proteases. Protein Sci 1995;4(3):337-60
  • Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004;303(5663):1532-5
  • Amulic B, Hayes G. Neutrophil extracellular traps. Cur Biol 2011;21(9):R297-8
  • Zawrotniak M, Rapala-Kozik M. Neutrophil extracellular traps (NETs) - formation and implications. Acta Biochim Pol 2013;60(3):277-84
  • Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 2010;191(3):677-91
  • Branzk N, Lubojemska A, Hardison SE, et al. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol 2014;15(11):1017-25
  • Arendrup MC. Epidemiology of invasive candidiasis. Curr Opin Crit Care 2010;16(5):445-52
  • Low CY, Rotstein C. Emerging fungal infections in immunocompromised patients. F1000 Med Repor 2011;3:14
  • Almyroudis NG, Grimm MJ, Davidson BA, et al. NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury. Front Immunol 2013;4:45
  • Hahn S, Giaglis S, Chowdhury CS, et al. Modulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology. Semin Immunopathol 2013;35(4):439-53
  • Mesa MA, Vasquez G. NETosis. Autoimmune Dis 2013;2013:651497
  • Obermayer A, Stoiber W, Krautgartner WD, et al. New aspects on the structure of neutrophil extracellular traps from chronic obstructive pulmonary disease and in vitro generation. PLoS One 2014;9(5):e97784
  • Yoo DG, Floyd M, Winn M, et al. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes. Immunol Lett 2014;160(2):186-94
  • Branzk N, Papayannopoulos V. Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol 2013;35(4):513-30
  • Caza T, Oaks Z, Perl A. Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus. Int Rev Immunol 2014;33(4):330-63

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.